Abstract
Tuberculosis (TB) continues to be an important and unresolved medical problem. About a quarter of mankind is infected with Mycobacterium tuberculosis, and about 5–10% of these people eventually develop TB. Macrophages and CD4+ T cells are considered the key cells providing defense against TB infection. The role of neutrophils in TB is less well defined. Neutrophils are short-lived granulocytes among first migrate into the infectious lung tissue and phagocy tose mycobacteria. On the one hand, there is evidence for protective role of neutrophils in TB released via anti-microbial peptides inhibiting mycobacterial growth, up-regulation of CD4+ T-cell activation, and dendritic cell migration in the lymph nodes. On the other hand, infection of genetically TB susceptible animals leads to an overwhelming lung neutrophil inflammation, development of necrotic granulomata, and a rapid death. Neutrophils act directly or indirectly on mycobacteria by different oxidative or other reactions including neutrophil extracellular traps (NETs) formation. Phagocytosis of mycobacteria by neutrophils is accompanied by the production of pro-inflammatory factors, thus making neutrophils active participants of inflammation in all stages of the infectious process. Finally, neutrophils die by apoptosis or necrosis. Necrosis of neutrophils, which is activated by reactive oxygen species, also prolongs the inflammation. In this way, there is strong evidence that neutrophils are the cells involved in the transition of infection to the terminal stage, participating in lung tissue destruction. Although neutrophils evolutionary developed many ways to resist pathogens, it is likely, that neutrophils do not possess sufficient anti-mycobactericidal capacities due to the development of many adaptations allowing mycobacteria to survive inside the neutrophils. Neutrophils effectively phagocytose but poorly kill mycobacteria, thus hiding bacilli from more efficient killers, macrophages, and playing the role of the “Trojan Horse”. In this review, we summarize the data on the involvement of neutrophils in TB inflammation. We discuss their ambiguous role in pathogenesis which depends upon mycobacterial virulence, host genetics, dynamics of migration to inflammatory foci, and persistence during initial and chronic stages of the infectious process.
Highlights
Tuberculosis (TB) continues to be an important and unresolved medical problem
There is evidence for protective role of neutrophils in TB released via anti-microbial peptides inhibiting mycobacterial growth, up-regulation of CD4+ T-cell activation, and dendritic cell migration in the lymph nodes
Infection of genetically TB susceptible animals leads to an overwhelming lung neutrophil inflammation, development of necrotic granulomata, and a rapid death
Summary
Нейтрофилы являются активными участниками воспаления на всех стадиях развития инфекционного процесса. В пользу этой теории свидетельствует исследование, демонстрирующее, что нейтрофилы являются предпочтительной нишей для размножения микобактерий у чувствительных к ТБ мышей на поздних сроках развития инфекционного процесса, тогда как эффективный Т-клеточный ответ направлен на элиминацию бактерий внутри макрофагов, но не нейтрофилов [41]. В этой же работе показано, что TLR2-зависимая продукция CXCL5 эпителиальными клетками легкого стимулирует приток нейтрофилов и способствует деструкции ткани легкого, тогда как выключение генов для CXCR2 или CXCL5 приводит к уменьшению патологии легких инфицированных животных. Показали, что цитокин IL-17 способствует накоплению нейтрофилов, продуцирующих S100A8/A9, которые в свою очередь индуцируют приток нейтрофилов и моноцитов посредством активации продукции провоспалительных хемокинов и цитокинов [66, 81], а также регулируя уровень экспрессии интегрина CD11b, необходимого для накопления нейтрофилов в легких. Большое количество цитокинов, хемокинов и других молекул, в том числе производимых самими нейтрофилами, прямо или опосредовано влияют на приток этих клеток в зараженное легкое
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.